Dr. Lorena Fernandes
Lorena obtained her 5-year bachelor degree in Pharmacy at the Federal University of Minas Gerais in Brazil (2015). During her final year she started working with liposomes and their use in Central Nervous Systems diseases. Her aim was to use liposomes as a drug carrier to treat brain disorders. In 2017 she completed her Masters in Pharmacology at the Federal University of Minas Gerais. Her research project's aim was to evaluate liposomal biodistribution on mice's body and brain following stroke. After that, she started her PhD, also in Pharmacology in the same department, and continued her work with liposomes in stroke now aiming to treat the disease and see the animals' recovery (developing a MCAO stroke model and treating the animals with liposomes). In October 2020 she joined the Nanomedicine Laboratory at the University of Manchester where she stayed for 6 months to do part of her PhD studies on stroke using liposomes. She went back to Brazil, finished her PhD in February 2022 and re-joined the Nanomedicine Lab at UoM in March 2022. Lorena has expertise in nanotechnology and neuroscience. She is now part of the NanoTherapeutics Team working as a Postdoctoral Research Associate at the Nanomedicine Lab. Her aim is to use 2D nanomaterial-based therapeutics for application in cancer therapy and to establish and maintain appropriate in vivo preclinical cancer models.